IL243348A0
(en )
2016-03-31
Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1
IL290547A
(en )
2022-04-01
Antibodies and methods of use
SG11201403834QA
(en )
2014-10-30
Combination therapy of antibodies against human csf-1r and uses thereof
EP3079719B8
(en )
2019-12-04
Anti-siglec-8 antibodies and methods of use thereof
IL249189A0
(en )
2017-01-31
Combination therapy of antibodies activating human cd40 and antibodies against human pd-l1
EP3065776A4
(en )
2017-04-19
Novel anti-claudin antibodies and methods of use
EP3080607A4
(en )
2017-07-12
Novel anti-dpep3 antibodies and methods of use
EP3065875A4
(en )
2018-02-07
Bioprinter and methods of using same
IL244495A0
(en )
2016-04-21
Anti-alpha-synuclein antibodies and methods of use
EP2925244A4
(en )
2017-02-22
Medical device and method of use
EP3038634A4
(en )
2017-10-11
Novel sez6 modulators and methods of use
EP3010938A4
(en )
2017-08-09
Fcrn-specific human antibody and composition for treatment of autoimmune diseases
EP3060253A4
(en )
2017-05-17
ANTI-Ly6E ANTIBODIES AND METHODS OF USE
EP3052525A4
(en )
2017-03-29
Anti-epcam antibodies and methods of use
EP3054974A4
(en )
2017-06-14
Glycan-interacting compounds and methods of use
WO2014144061A9
(en )
2014-12-11
Flavivirus neutralizing antibodies and methods of use thereof
EP3027182A4
(en )
2017-04-12
Novel copper-cysteamine and methods of use
EP3060580A4
(en )
2017-03-29
Anti-podocalyxin antibodies and methods of using the same
EP2970462A4
(en )
2017-02-22
Anti-rankl antibodies and methods of use
EP3065691A4
(en )
2018-01-10
Apparatus and methods of use
HK40114296A
(en )
2025-03-07
Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1
EP3046937A4
(en )
2017-04-26
Modified anti-inflammatory proteins and method of use
HK40092146A
(en )
2023-12-22
Anti-cd3 antibodies and methods of use
EP3046575A4
(en )
2017-04-05
Anti-inflammatory proteins and methods of use
EP3071207A4
(en )
2017-08-16
Libido-enhancing therapeutic and use